Shares of Johnson & Johnson dipped 2% on Wednesday after a jury awarded $8 billi...
- Shares of Johnson & Johnson dipped 2% on Wednesday after a jury awarded $8 billion in punitive damages to a man who accused the drugmaker of failing to warn that young men using its antipsychotic drug Risperdal could grow breasts.
But several said that J&J’s shares were now exposed to fears among investors that it would be hammered by further litigation costs as it battles other claims over Risperdal, its opioid treatments and talcum powder. Wells Fargo analyst Lawrence Biegelsen said the $8 billion figure will “almost certainly be reduced”.
In 2013, Johnson & Johnson paid more than $2.2 billion to resolve civil and criminal investigations by the U.S. Department of Justice into its marketing of Risperdal and other drugs.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson Ordered To Pay $8 Million In Male Breast Growth CaseJ&J said it would appeal the decision.
Read more »
J&J Hit With $8 Billion Jury Award Over Antipsychotic DrugA Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a man who said his use of J&J’s antipsychotic Risperdal caused enlarged breasts.
Read more »
Jury says J&J must pay $8 billion in case over male breast growth linked to RisperdalJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Read more »
'I Wore $8 Press-Ons for A Month, And My Nails Have Never Been Healthier'I wore press-ons for one month straight, and my nails have never been healthier. These are my favorite picks.
Read more »
J&J must pay $8 billion in case over male breast growth linked to Risperdal: juryJohnson & Johnson must pay $8 billion in punitive damages to a man who previousl...
Read more »